We are live on ! Find out more
LABD icon

Direxion Daily S&P Biotech Bear 3X ETF
LABD

18 hedge funds and large institutions have $23.1M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

173% more capital invested

Capital invested by funds: $8.45M → $23.1M (+$14.7M)

38% more funds holding

Funds holding: 13 → 18 (+5)

0% more ownership

Funds ownership: 0% → 0.01% (+0%)

46% less call options, than puts

Call options by funds: $824K | Put options by funds: $1.54M

Holders
18
Holders Change
+5
Holders Change %
+38.46%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
2
Closed
–
Calls
$824K
Puts
$1.54M
Net Calls
-$712K
Net Calls Change
-$2.17M

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$17.3M
2
SG Americas Securities
SG Americas Securities
New York
+$2.88M
3
VF
Virtu Financial
New York
+$2.15M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.04M
5
TSS
Two Sigma Securities
New York
+$519K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$557K
2
Jane Street
Jane Street
New York
-$38.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
1
Citigroup
New York
$12.4M +$17.3M +900 New
VF
2
Virtu Financial
New York
$2.76M +$2.15M +112 +127%
SG Americas Securities
3
SG Americas Securities
New York
$2.3M +$2.88M +150 +882%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$1.61M +$1.04M +54 +86%
CS
5
Credit Suisse
Switzerland
$1.03M – – –
TRCT
6
Tower Research Capital (TRC)
New York
$1.02M +$154K +8 +12%
TSS
7
Two Sigma Securities
New York
$526K +$519K +27 +245%
Citadel Advisors
8
Citadel Advisors
Florida
$368K -$557K -29 -52%
VKH
9
Virtu KCG Holdings
New York
$328K +$346K +18 +300%
HF
10
HRT Financial
New York
$155K +$211K +11 New
CT
11
CMT Trading
Illinois
$145K +$57.6K +3 +38%
Goldman Sachs
12
Goldman Sachs
New York
$106K +$154K +8 New
Jane Street
13
Jane Street
New York
$95K -$38.4K -2 -22%
Simplex Trading
14
Simplex Trading
Illinois
$87K +$76.9K +4 +200%
TCM
15
Tradewinds Capital Management
Washington
$69K +$96.1K +5 New
UBS Group
16
UBS Group
Switzerland
$34K +$38.4K +2 New
Morgan Stanley
17
Morgan Stanley
New York
$25K +$19.2K +1 +100%
CG
18
Cutler Group
California
$23K – – –
TWA
19
TCI Wealth Advisors
Arizona
$1K – – –

LABD Hedge Fund Activity: Q2 2017 in Review

18 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2017, worth a combined $23.1M — up 173% from $8.45M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new LABD positions and 0 closed out — a net gain of 5 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was Citigroup, opening a new position worth an estimated $17.3M. The largest seller was Citadel Advisors, cutting an estimated $557K.

  • 18 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2017, up from 13 in Q1 2017.
  • Funds reported $23.1M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2017, up 173% quarter-over-quarter.
  • 5 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2017 and 0 closed out, a net change of +5 holders.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2017 was Citigroup, an estimated $17.3M added.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2017 was Citadel Advisors, an estimated $557K sold.

Based on aggregated 13F filings for Q2 2017.